Dermatology and Psoriasis
Dice Therapeutics Inc. concentrates its clinical research on plaque psoriasis, with studies centered on moderate-to-severe disease in adult participants. The company’s trial portfolio reflects a clear interest in skin inflammation and immune-mediated dermatologic disorders.
- Plaque psoriasis
- Moderate-to-severe psoriasis
- Adult dermatology
Its research activity includes evaluation of therapeutic candidates intended to address the clinical burden of persistent psoriatic skin disease.
Immunology and Inflammatory Disease
The sponsor’s work is closely aligned with immune-mediated inflammation, particularly conditions where abnormal immune signaling drives chronic skin symptoms. The funded trials indicate an ongoing focus on treatments for inflammatory pathways relevant to psoriatic disease.
- Immune-mediated inflammation
- Inflammatory skin disease
- Psoriatic disease
This area of interest connects therapeutic development with diseases that require targeted control of inflammatory activity.
Healthy Volunteer Research
Alongside disease-focused studies, Dice Therapeutics Inc. supports clinical research in healthy male participants to examine pharmacokinetics, metabolism, and excretion. These studies help define how candidate therapies behave in the body outside the disease setting.
- Healthy volunteers
- Pharmacokinetics
- Metabolism
The inclusion of healthy-participant research shows attention to foundational human data for orally administered compounds.
